Material and Methods. This was a prospective non-randomized controlled study that included 24 infants who were treated in the intensive care unit of Children's Regional Clinical Hospital from 2010 to 2011. The inclusion criteria were as follows: 1) the presence of congenital anomalies of the gastrointestinal tract (GIT) that were diagnosed prenatally and 2) a surgical procedure in the first days after the diagnosis of surgical disease. The control points in the study were the number and type of septic complications and duration of mechanical ventilation. The exclusion criteria were multiple congenital anomalies and the child's death during the first day after surgery.
All of the children belonged to a group at high risk for postoperative septic complications, and at least one of the following factors was present: 1) the late arrival of newborns on the stage of specialized care, 2) transportation failure to comply with the standards by non-specialized vehicles, 3) longterm (over 15 min) hypothermia.
The children were divided into two groups. Group 1 (n=10) included newborns with inflammatory complications after surgery, and group 2 (n=14) included children who had no complications after surgery. The control group consisted of healthy newborns (n=20) after a normal physiological birth. The structure of the GIT congenital anomalies is presented in Table. All of the children underwent surgical correction of the congenital anomaly on the first or second day after diagnosis. Patients in both groups at all stages of care received complex intensive care in compliance with generally accepted principles of treatment in neonatology, pediatric surgery and anesthesiology and intensive care. The vital signs of all the children were monitored via ECG monitoring of systolic, diastolic and mean arterial pressure by non-invasive method and tissue oxygen saturation (SaO 2 ). The hematocrit was controlled before and after the injection of solutions. The following blood parameters were determined: total protein, electrolytes (Na, Ca, K), sugar, creatinine, urea and liver enzymes (ALT, AST, alkaline phosphatase). The blood plasma BPI level was determined in the children preoperatively and on the 1 st , 3 rd , 7 th and 14 th postoperative days. The level of BPI «BCM Diagnostics» was determined using an ELISA.
The analysis of the reliability of the differences between the groups was carried out by methods of variation statistics using the licensed computer program Statistica 6.0. The data were reviewed using the Shapiro-Wilk method to choose an adequate method of statistical analysis. This result (p=0.36) suggests the need for nonparametric statistical methods. We used the Wilcoxon test to analyze the statistical reliability between the groups. The critical significance level (p) for verification of the statistical hypotheses in this study was set at 0.05. The median (Me) interquartile range was 25 -75 %.
Results. In group 1, the post-operative complications included anastomotic obstruction (n=2), leakage at the anastomosis and prolonged adynamic ileus (n=3), and sepsis or pneumonia (n=5).
The level of BPI in group 1 was 3.33 (2.74-4.51) ng/ml preoperatively and 4.49 (1.48-5.7) ng/ml on the first postoperative day. After 3 days, the BPI level increased markedly to 15.75 (3.32-50.5) ng/ ml and then decreased gradually on day 7 to 4.425 (3.38-55.4) ng/ml and to 3.23 (0.01-30.9) ng/ml 14 days after the operation (Fig. 1 ).
In group 2, the BPI level was 10.5 (3.35-19.05) ng/ml preoperatively. On the 1st postoperative day, it decreased to 2.755 (1.835-6.545) ng/ml, and on postoperative day 3, the level remained stable at 2.915 (1.37-55.5) ng/ml. The BPI level increased on the 7 th postoperative day to 33.45 (21.7-45.2) ng/ml and remained unchanged by the 14 th postoperative day at 34.5 (34.5-34.5) ng/ml (Fig. 2) . When comparing the baseline BPI level, which increases the permeability of the cells in the treatment groups, using the Wilcoxon test, significant differences were detected (p>0.05). Significant differences (p>0.05) were detected between the serum BPI level in the serum of children in group 1 and group 2. There was a statistically significant (p<0.05) increase in the serum BPI level in group 1 on the 3rd postoperative day. The level of bactericidal protein was significantly higher on the 1st postoperative day (p<0.05) in group 2.
Discussion. The production of AMPs is commonly considered a primitive mechanism of immunity. The antimicrobial activity of saliva largely depends on histidine-rich AMPs known as histatins. Many more AMPs and AMP-like proteins exist and exhibit various functions apart from their antimicrobial properties. The AMP-like protein of the neutrophil granule content, bactericidal/permeability increasing protein (BPI), is able to permeabilize bacterial membranes and function as an opsonin [7] . BPI stored in azurophil granules is a major constituent of neutrophils (0.5 to 1 % of total protein) and is present in eosinophils in smaller amounts. The epithelial cells of the oral, gastrointestinal and female genital tracts produce BPI [8] .
The potent and selective antibiotic and endotoxin-neutralizing properties of BPI manifest with nM concentrations of either the full-length BPI molecule or rBPI21 stimulated extensive preclinical and clinical testing of rBPI21. In a variety of animal models, recombinant human BPI (rBPI) and its amino-terminal derivate (rBPI21) were protective against lethal and sub-lethal challenges with Gram-negative bacteria and endotoxin [5] . Subsequent studies in humans, including studies in meningococcal sepsis, showed a significant protective effect of BPI, although it is not yet sufficient to be approved for clinical application. These studies strongly suggested that BPI can act in vivo to help resolve Gram-negative bacteria infections and endotoxin-induced inflammation [9] In an open label, dose-escalation phase I/II trial, 26 pediatric patients with fulminant meningococcal sepsis were treated with rBPI21 administered Only one of the patients (4 %) died, which favorably compared to a historical control group with 20 % mortality (11 of 54 patients). In a subsequent phase III, randomized, placebo-controlled trial, 190 patients received rBPI21 and 203 received placebo. The beneficial effect of rBPI21 could be confirmed. The reduction in mortality did not reach statistical significance, probably because the study was underpowered by an inappropriate design not taking into account the high mortality of patients in the time between recruitment and drug administration [10] . BPI can induce apoptosis in human vascular endothelial cells in vitro and inhibit their migration in a wound assay [11] . The amino-terminal part of BPI (rBPI21) inhibited ischemia-induced or diabetesinduced neo-vascularization in the retina of mice, suggesting an antiangiogenetic effect of BPI. It is conceivable that BPI could impair the vascular access of GNB by inhibiting neo-angiogenesis in settings where chronic neutrophilic inflammation prevails, e.g., in inflammatory bowel diseases [12] .
BPI is a pluripotent protein located in neutrophils and tissue that likely plays a pivotal role in host defense against microorganisms and endotoxin by means of its antibiotic and endotoxin-neutralizing and disposing functions. Further studies are needed to understand how BPI expression is controlled in different tissue cells. A better understanding of the regulation of BPI expression in epithelial and connective tissue settings may suggest novel approaches to increase the local antibacterial and anti-inflammatory properties and may be especially useful in newborns with congenital GI anomalies. Conclusion 1. The high level of BPI after surgery in infants with a congenital anomaly on the first postoperative day is a favorable prognostic sign regarding the disease outcome.
2. Initially, low levels of BPI in the serum of a child in conjunction with increased levels on the third day can serve as a marker of an unfavorable outcome, but further research is required in this area.
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The aim of this study was to investigate the influence of bactericidal/permeability-increasing protein (BPI) on the development of complications after abdominal surgery in infants
We investigated the intestinal hormone levels in the blood before and after surgery (1, 3, 7 and 14 postoperative days) in 24 infants with congenital intestinal obstruction anomaly and atresia. The children were divided into group 1 (N=10), which included newborns with inflammatory complications after the surgery, and group 2 (N=14), which included newborns without inflammatory complications. Twenty infants without operative treatment formed the control group. The level of BPI was determined by ELISA. У 24 новорожденных с врожденной хирурги-ческой патологией ЖКТ перед операцией и на 1, 3, 7, 14 послеоперационные сутки исследо-вали уровень BPI в сыворотке крови. Были вы-делены 2 группы: группа № 1 (n=10) -дети с по-слеоперационными осложнениями, группа № 2 (n=14) -дети без осложнений.
Уровень BPI перед операцией в группе № 2 был выше, чем в группе № 1 (10.5 ng/ml (3, ,05) и 3,33 ng/ml (2,74-4,51), p<0,05, соот-The level of BPI before surgery in group 2 was significantly higher than that in group 1 (10.5 ng/ml (3.35-19.05) and 3.33 ng/ml (2.74-4.51) p<0.05, respectively). In a group data comparison, BPI was significantly higher in group 1, even on the third day after surgery (2.915 ng/ml (1.37-55.5) and 15.75 ng/ml (3.32-50.5) p<0.05, respectively). The data showed values of BPI in the group of patients with inflammatory complications that were higher than those in the main and comparison groups from the third postoperative day.
The increased BPI in the blood on the first postoperative day in newborns was a good prognostic sign. An initial low level BPI and the increased BPI in the blood on the third postoperative day in newborns was a poor prognostic sign and was evidence of development of inflammatory complications.
Key words: gastrointestinal tract, congenital anomaly, infants, bactericidal/permeability-increasing protein ветственно). При сравнении показателей BPI на третий день после операции отмечалось значительное (р<0.05) его повышение в груп-пе № 1 (15,75 ng/ml (3,32-50,5)) по сравнению с группой № 2 (2,915 ng/ml (1,37-55,5)). Уста-новлено статистически достоверное (p<0,05) увеличение уровня BPI на 3-и сутки у пациен-тов с послеоперационными осложнениями.
Таким образом, высокий уровень BPI у ново-рожденных с хирургической патологией ЖКТ в 1-е сутки благоприятный прогностический при-знак. Исходно низкий уровень BPI в сыворотке крови ребенка в сочетании с его нарастанием на 3-и сутки может служить маркером развития по-слеоперационных осложнений.
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